Pharmacological Targeting of the ER-Resident Chaperones GRP94 or Cyclophilin B Induces Secretion of IL-22 Binding Protein Isoform-1 (IL-22BPi1).


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 May 2019
Historique:
received: 29 04 2019
revised: 14 05 2019
accepted: 15 05 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 13 11 2019
Statut: epublish

Résumé

Of the three interleukin-22 binding protein (IL-22BP) isoforms produced by the human

Identifiants

pubmed: 31108847
pii: ijms20102440
doi: 10.3390/ijms20102440
pmc: PMC6566634
pii:
doi:

Substances chimiques

Benzoquinones 0
Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
IL22RA2 protein, human 0
Lactams, Macrocyclic 0
Membrane Glycoproteins 0
Protein Isoforms 0
Receptors, Interleukin 0
endoplasmin 0
cyclophilin B 137497-17-7
Cyclosporine 83HN0GTJ6D
Cyclophilins EC 5.2.1.-
geldanamycin Z3K3VJ16KU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Osasun Saila, Eusko Jaurlaritzako
ID : IT512-10, PPG17/44
Organisme : Ministerio de Economía y Competitividad
ID : SAF2016-74891R

Références

Biochem J. 2000 Dec 15;352 Pt 3:865-74
pubmed: 11104697
J Biol Chem. 2001 May 25;276(21):17920-31
pubmed: 11279020
J Immunol. 2001 Jun 15;166(12):7090-5
pubmed: 11390453
J Immunol. 2001 Jun 15;166(12):7096-103
pubmed: 11390454
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9511-6
pubmed: 11481447
Nat Cell Biol. 2001 Oct;3(10):891-6
pubmed: 11584270
J Biol Chem. 2003 Feb 28;278(9):7459-68
pubmed: 12397072
Mol Biol Cell. 2002 Dec;13(12):4456-69
pubmed: 12475965
Genes Immun. 2003 Apr;4(3):204-11
pubmed: 12700595
Genes Immun. 2004 Aug;5(5):330-6
pubmed: 15201862
Mol Cells. 2005 Oct 31;20(2):173-82
pubmed: 16267390
Cell. 1991 Aug 23;66(4):807-15
pubmed: 1715244
J Immunol. 2007 May 1;178(9):5973-81
pubmed: 17442982
Nat Cell Biol. 2008 Mar;10(3):272-82
pubmed: 18264092
Structure. 2008 Sep 10;16(9):1333-44
pubmed: 18599299
J Cell Sci. 2008 Nov 1;121(Pt 21):3636-48
pubmed: 18946027
FEBS Lett. 2009 Apr 2;583(7):1072-7
pubmed: 19285080
Semin Cell Dev Biol. 2010 Jul;21(5):479-85
pubmed: 20223290
Epigenetics. 2011 Jan;6(1):45-51
pubmed: 20818162
PLoS One. 2010 Sep 28;5(9):null
pubmed: 20927389
Br J Pharmacol. 2011 Jan;162(2):328-45
pubmed: 20942857
J Invest Dermatol. 2011 May;131(5):1085-94
pubmed: 21270823
Int Immunol. 2011 Mar;23(3):159-63
pubmed: 21393631
J Am Chem Soc. 2012 Jun 13;134(23):9796-804
pubmed: 22642269
Mol Cell Proteomics. 2012 Sep;11(9):710-23
pubmed: 22665516
Nature. 2012 Nov 8;491(7423):259-63
pubmed: 23075849
Semin Immunopathol. 2013 May;35(3):351-73
pubmed: 23572207
Mucosal Immunol. 2014 Jan;7(1):101-13
pubmed: 23653115
Nat Rev Drug Discov. 2014 Jan;13(1):21-38
pubmed: 24378801
Cytokine Growth Factor Rev. 2014 Jun;25(3):257-71
pubmed: 24856143
J Biol Chem. 2014 Aug 15;289(33):23086-96
pubmed: 24990953
Genes Immun. 2014 Oct;15(7):457-65
pubmed: 25008863
Bioinformatics. 2014 Dec 15;30(24):3561-6
pubmed: 25172926
Expert Opin Ther Targets. 2015;19(9):1203-18
pubmed: 26166159
Mucosal Immunol. 2016 Mar;9(2):539-49
pubmed: 26329427
Acta Pharmacol Sin. 2016 Apr;37(4):425-43
pubmed: 26838072
J Biol Chem. 2016 Apr 29;291(18):9526-39
pubmed: 26945068
Curr Top Med Chem. 2016;16(25):2779-91
pubmed: 27072700
Sci Signal. 2016 Sep 27;9(447):ra95
pubmed: 27678220
J Immunol. 2017 May 1;198(9):3671-3678
pubmed: 28356382
J Exp Med. 2017 Jun 5;214(6):1607-1618
pubmed: 28512157
Sci Rep. 2018 Mar 23;8(1):5085
pubmed: 29572462
Hum Vaccin Immunother. 2018;14(8):2012-2015
pubmed: 29617184
Front Immunol. 2018 Dec 14;9:2934
pubmed: 30619294
Immunohorizons. 2018 Jul 5;2(6):198-207
pubmed: 31022687
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3931-5
pubmed: 7909608
J Biol Chem. 1996 Sep 13;271(37):22796-801
pubmed: 8798456

Auteurs

Paloma Gómez-Fernández (P)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. paloma.gomez.fernandez@gmail.com.

Andoni Urtasun (A)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. a.urtasun.arricaberri@gmail.com.

Ianire Astobiza (I)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. nireaspe@hotmail.com.

Jorge Mena (J)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. jorgemena65@outlook.com.

Iraide Alloza (I)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. iraide.alloza@ehu.eus.

Koen Vandenbroeck (K)

Neurogenomiks Group, Department of Neuroscience, University of the Basque Country (UPV/EHU), 48490 Leioa, Spain. k.vandenbroeck@ikerbasque.org.
IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain. k.vandenbroeck@ikerbasque.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH